Researcher develops, tests nano-carrier as potential treatment for glioblastomas
The unveiling of a novel mechanism of resistance to immunotherapy targeting HER2
23 February 2021Prospective study finds light activity, such as gardening or walking, preserves women’s mobility during aging
23 February 2021Researcher develops, tests nano-carrier as potential treatment for glioblastomas
With a survival rate of only five years, the most common and aggressive form of primary brain tumor, glioblastoma multiforme, is notoriously hard to treat using current regimens that rely on surgery, radiation, chemotherapy and their combinations.
